| abstract |
The present invention relates to enantiomers of the novel tetrahydroisoquinoline compounds, pharmaceutically acceptable salts thereof, methods for their preparation, and uses thereof, and specifically myocardial contractility according to the enantiomer forms (types S and R). The pharmaceutical composition containing tetrahydroisoquinoline-based compounds as an active ingredient, exhibiting potentiation, antithrombotic action, vasorelaxation and iNOS inhibition, is used for the treatment of sepsis, blood pressure lowering agents, platelet aggregation inhibitors, anti-inflammatory agents, DIC therapies, and heart failure. It can be usefully used as a therapeutic agent.n n n n Tetrahydroisoquinoline compounds, enantiomers. |